AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.Dado Ruvic ...
Tag: Health care industry
Nvidia rally is fueling FOMO in the overall market, Evercore’s Julian Emanuel warns
Evercore ISI's Julian Emanuel thinks Nvidia's monster rally is fueling a fear of missing out in the market.He finds clients, ...
Oil stocks share a bullish similarity with semis, but ‘no one cares,’ VanEck CEO says
Investors may want to consider putting money to work in a lagging part of the market.According to VanEck CEO Jan ...
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. Victoria ...
Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet ...
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New ...
Elon Musk’s Neuralink implants brain tech in human patient for the first time
Jonathan Raa | Nurphoto | Getty ImagesElon Musk's neurotech startup Neuralink implanted its device in a human for the first ...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, ...
Gilead stock falls after disappointing lung cancer study results
Sopa Images | Lightrocket | Getty ImagesShares of Gilead fell more than 9% on Monday after a key drug from ...
